Third-party clamp mobile health platform terminal consumers are very passive

Release date: 2014-06-24

Smart watches, health applications... When Samsung and Apple "twisted" in the field of health data tracking and its solutions, Google suddenly announced that it would launch its own Android health platform at this week's I/O conference. On the other hand, although Microsoft has not clearly expressed its keen interest in digital medical treatment, it already has the HealthVault personal health management platform, not to mention the recent news that Microsoft will also launch a smart watch that can match it...

It can be said that nowadays, the major IT giants are rushing to the horses, and when the battle of the mobile health platform starts, this may be just a matter of timing. However, if we still want to predict this win or lose with the traditional mode of thinking, then I am afraid it is a big mistake - the mobile health platform will no longer be just a pure consumer-driven market.

Technology media Fool published a commentary today that medical IT companies may become the core of the digital healthcare market.

The so-called health IT company refers to a third-party enterprise that produces electronic health record systems and equipment. The so-called consumer. Individuals who are no longer receiving medical services in their own form can be doctors, hospital administrators, and more likely health IT specialists. Especially in large medical institutions, IT departments and managers will not only purchase large-scale digital medical equipment, but also play a more important decision-making role in the acceptance of digital medical equipment by medical institutions. So how will medical security IT companies affect the direction of the entire market?

The level of ability of users to share their health data with doctors, hospitals, etc., or ultimately determine the development of the entire market, especially for patients with chronic diseases. Because of the long-term monitoring and data management of medical institutions, the business value created by patients will also More. In other words, whether a healthcare app is developed specifically for a surgical operation in a medical institution or as a healthy IT solution will be determined by the healthcare provider.

For example: It is understood that Apple announced at the Global Developers Conference that the company has just recently established a partnership with Epic Systems, the leader in electronic health records, and its application for patient-developed electronic health file application MyChart will also be bundled with Apple. .

Why is this transaction important? Because it means that Epic is a third-party supplier to the famous American medical institutions such as the Cleveland Clinic and Johns Hopkins Hospital, and its acceptance of Apple will be decided. The acceptance of digital healthcare by many medical institutions – HealthKit users must authorize Apple to share their health data with MyChart before being transferred to a doctor by MyChart. Although HealthKit can have many personal data on mobile phones, it is up to Epic medical service providers to decide which data is useful and which health applications and devices meet the reliability and effectiveness requirements.

Unlike the competition between Mac and PC, iOS and Android, Samsung and Apple, this time, the terminal consumers' voice is weakened, and the "rights" of third-party intermediary organizations are infinitely magnified. In the face of such a market, we still need a long time to optimize and upgrade it.

In the end, is 1V1 accepting a certain health management platform, or is the open access end of 1VN, whether it is receiving a certain service or receiving it in its entirety? From the current point of view, it is ostensibly determined by the patient, but actually The final decision is still a medical service provider.

With the development of the digital medical and health industry, we are not aware of how the entire market will change in the future. However, it can be confirmed that the situation in which the third party is connected at both ends will be changed.

Source: Sohu IT

Olive Leaf Extract

10% Oleuropein And Hydroxytyrosol Olive Leaf Extract is one kind of Olive Leaves Extract which is one Key Products Of Our Company. They Are Extracted, Concentrated And Dried From The Leaves Of Olive.

Olive Leaf Extract is a Broad-Spectrum Antimicrobial Ingredient Taken Orally.So Far The Most Active Compounds Identified In Olive Leaves Are Olivine, a Class Of Bitter Monosaponins That Are Classified As Ridoids.Olivopicrin And Its Hydrolyzed Products Have Special Significance For The Antibacterial Function Of Olive Leaves.

Olive is a Famous Subtropical Fruit Tree.China's Distribution In Fujian Province As The Most, Sichuan, Zhejiang, Taiwan And Other Parts Of The Region Also Have Distribution.Cultivation Of Olive Countries In Addition To China, Vietnam, Laos, Cambodia, Thailand, Burma, India And Malaysia.

Olive Leaf

Our oliver leaf base

Olive Leaf2

Function Of Olive Leaves

1. Broad-Spectrum Antimicrobial Action

2. Antioxidation

3. Strengthen The Immune System

4. Slower Cardiovascular Disease

Application Of Olive Leaf Extract

1. Iridoids Were The Main Components Of Olive Leaf Extract, And Oleuropein And Hydroxytyrosol Were The Most Active.It Is Widely Used In Health Products And Cosmetics.

2. Used In Medicine, Health Food, Skin Care Products, Etc


Olive Leaf Extract,An Olive Leaf Extract,Olive Leaf Extract Powder,Herpe Extract Olive Leaf

Shaanxi Kepler Biotech Co.,Ltd , https://www.keplerherb.com